These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 24555521)

  • 1. Comparison of the effectiveness of virtual cue exposure therapy and cognitive behavioral therapy for nicotine dependence.
    Park CB; Choi JS; Park SM; Lee JY; Jung HY; Seol JM; Hwang JY; Gwak AR; Kwon JS
    Cyberpsychol Behav Soc Netw; 2014 Apr; 17(4):262-7. PubMed ID: 24555521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized clinical trial of cue exposure treatment through virtual reality for smoking cessation.
    Pericot-Valverde I; Secades-Villa R; Gutiérrez-Maldonado J
    J Subst Abuse Treat; 2019 Jan; 96():26-32. PubMed ID: 30466545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
    Shiffman S
    Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intolerance for smoking abstinence among nicotine-deprived, treatment-seeking smokers.
    Germeroth LJ; Baker NL; Saladin ME
    Addict Behav; 2018 Sep; 84():13-19. PubMed ID: 29597136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Individual variables related to craving reduction in cue exposure treatment.
    Pericot-Valverde I; García-Rodríguez O; Gutiérrez-Maldonado J; Secades-Villa R
    Addict Behav; 2015 Oct; 49():59-63. PubMed ID: 26047836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decline in cue-provoked craving during cue exposure therapy for smoking cessation.
    Unrod M; Drobes DJ; Stasiewicz PR; Ditre JW; Heckman B; Miller RR; Sutton SK; Brandon TH
    Nicotine Tob Res; 2014 Mar; 16(3):306-15. PubMed ID: 24078760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicotine craving and cue exposure therapy by using virtual environments.
    Lee J; Lim Y; Graham SJ; Kim G; Wiederhold BK; Wiederhold MD; Kim IY; Kim SI
    Cyberpsychol Behav; 2004 Dec; 7(6):705-13. PubMed ID: 15687806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of D-cycloserine on cue-induced craving and cigarette smoking among concurrent cocaine- and nicotine-dependent volunteers.
    Yoon JH; Newton TF; Haile CN; Bordnick PS; Fintzy RE; Culbertson C; Mahoney JJ; Hawkins RY; LaBounty KR; Ross EL; Aziziyeh AI; La Garza R
    Addict Behav; 2013 Feb; 38(2):1518-1526. PubMed ID: 22560371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VIRTUAL REALITY CUE EXPOSURE THERAPY FOR THE TREATMENT OF TOBACCO DEPENDENCE.
    Culbertson CS; Shulenberger S; De La Garza R; Newton TF; Brody AL
    J Cyber Ther Rehabil; 2012; 5(1):57-64. PubMed ID: 25342999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cue exposure treatment in a virtual environment to reduce nicotine craving: a functional MRI study.
    Moon J; Lee JH
    Cyberpsychol Behav; 2009 Feb; 12(1):43-5. PubMed ID: 19025463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Withdrawal Symptoms and Nicotine Dependence Severity Predict Virtual Reality Craving in Cigarette-Deprived Smokers.
    Thompson-Lake DG; Cooper KN; Mahoney JJ; Bordnick PS; Salas R; Kosten TR; Dani JA; De La Garza R
    Nicotine Tob Res; 2015 Jul; 17(7):796-802. PubMed ID: 25475087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased self-efficacy to quit and perceived control over withdrawal symptoms predict smoking cessation following nicotine dependence treatment.
    Schnoll RA; Martinez E; Tatum KL; Glass M; Bernath A; Ferris D; Reynolds P
    Addict Behav; 2011; 36(1-2):144-7. PubMed ID: 20869812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of nicotine lozenge use prior to smoking cue presentation on craving and withdrawal symptom severity.
    Kotlyar M; Vogel RI; Dufresne SR; Mills AM; Vuchetich JP
    Drug Alcohol Depend; 2020 Jan; 206():107706. PubMed ID: 31757519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extended treatment for cigarette smoking cessation: a randomized control trial.
    Laude JR; Bailey SR; Crew E; Varady A; Lembke A; McFall D; Jeon A; Killen D; Killen JD; David SP
    Addiction; 2017 Aug; 112(8):1451-1459. PubMed ID: 28239942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of systematic cue exposure through virtual reality on cigarette craving.
    Pericot-Valverde I; Secades-Villa R; Gutiérrez-Maldonado J; García-Rodríguez O
    Nicotine Tob Res; 2014 Nov; 16(11):1470-7. PubMed ID: 24962558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of repeated virtual nicotine cue exposure therapy on the psychophysiological responses: a preliminary study.
    Choi JS; Park S; Lee JY; Jung HY; Lee HW; Jin CH; Kang DH
    Psychiatry Investig; 2011 Jun; 8(2):155-60. PubMed ID: 21852993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A placebo-controlled randomized trial of D-cycloserine augmentation of cue exposure therapy for smoking cessation.
    Otto MW; Pachas GN; Cather C; Hoeppner SS; Moshier SJ; Hearon BA; Ward HB; Laffer AB; Smits JAJ; Evins AE
    Cogn Behav Ther; 2019 Jan; 48(1):65-76. PubMed ID: 30111253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Delay Discounting and Other Predictors on Smoking Relapse.
    González-Roz A; Secades-Villa R; Pericot-Valverde I; Weidberg S; Alonso-Pérez F
    Span J Psychol; 2019 Mar; 22():E9. PubMed ID: 30885283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A controlled trial of bupropion added to nicotine patch and behavioral therapy for smoking cessation in adults with unipolar depressive disorders.
    Evins AE; Culhane MA; Alpert JE; Pava J; Liese BS; Farabaugh A; Fava M
    J Clin Psychopharmacol; 2008 Dec; 28(6):660-6. PubMed ID: 19011435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive behavioral therapy and the nicotine transdermal patch for dual nicotine and cannabis dependence: a pilot study.
    Hill KP; Toto LH; Lukas SE; Weiss RD; Trksak GH; Rodolico JM; Greenfield SF
    Am J Addict; 2013; 22(3):233-8. PubMed ID: 23617864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.